Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Panbela Therapeutics Inc
PBLA
Healthcare
Biotechnology
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is involved in enrolling patients in its randomized double-blind placebo-controlled clinical trial for the treatment of pancreatic cancer. The Company's lead assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X). Ivospemin is a polyamine analog designed to...
induce polyamine metabolic inhibition (PMI). Flynpovi is a combination of CPP-1X (eflornithine) and sulindac. It has a dual mechanism of action whereby it suppresses the synthesis of new polyamines and increases the export and catabolism of polyamines from the diet and microbiome. Eflornithine is being developed as a single-agent tablet or high-dose powder sachet for several indications, including prevention of gastric cancer, treatment of neuroblastoma and recent onset Type 1 diabetes metastatic castration-resistant prostate cancer, and STK-11 mutant NSCLC.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:PBLA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 02, 2024 11:30am
Panbela Therapeutics, Inc. (PBLA): Navigating the Challenges
https://beyondspx.com/2024/07/31/panbela-therapeutics-inc-pbla-navigating-the-challenges-of-advancing-innovative-therapeutics/
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 15, 2024 8:00am
New Press Release - Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
MINNEAPOLIS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that, has regained compliance with applicable listing...
read article.
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 01, 2024 7:00am
New Press Release - Panbela Announces Closing of Approximately $9.0 Million Public Offering
MINNEAPOLIS, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the closing of its previously announced public offering of (i) 4,375...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 30, 2024 8:15am
New Press Release - Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
MINNEAPOLIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer today announced that an abstract for SBP-101, a proprietary polyamine analogue, has...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Jan 29, 2024 8:46am
RE:PBLA ..... JUst remember what this game is all about!!!!
All I can say to all those that didn't listen is ....... I fore-warned you! Here is this a.m's NR...... Panbela Announces Pricing of Approximately $9.0 Million Public Offering 2024-01-29
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jan 29, 2024 6:15am
New Press Release - Panbela Announces Pricing of Approximately $9.0 Million Public Offering
MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the pricing of a public offering of (i) 4,375,000 shares of its...
read article.
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 26, 2024 3:58pm
PBLA .... I wish u all the best during AH
I don't trade After Hours Just remember that there will be a P.O announcement sooner than later and the share price will tank Cheers !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 26, 2024 3:48pm
PBLA .... I am keeping all my profit
Not giving The Maggot squat ; ) Don't care where it goes to
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 26, 2024 3:45pm
PBLA ....you just might be surprised how fast this can rip
15 mis left before the close
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 26, 2024 3:43pm
PBLA....don't get greedy
Cheers !
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Jan 26, 2024 3:42pm
RE:PBLA ....And just for the record.....
Here we Go Packers ...Here We Go !!!!!
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 26, 2024 2:38pm
PBLA ....And just for the record.....
I still think that this will get another run before the close. I'm not hanging around to see any carnage Just my humble opinion. Have a great weekend.......make sure you take a look at AVTX ;
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Jan 26, 2024 2:33pm
RE:PBLA...now wouldn't that be hilarious if this....
I am not greedy...........Scalped again As previously mentioned...I like to leave some profit for the next guy ; ) Thats enough for me....I'm going to let the dust settle....not going to swing
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Jan 26, 2024 2:11pm
PBLA...now wouldn't that be hilarious if this....
Tacked on another buck from here????
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Jan 26, 2024 2:10pm
RE:RE:PBLA ....vols are minimal at best
How's it working out for everyone???? Time to like my prognostications??? Maybe
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments